Highlights
Recent News
Microsoft’s Cost-Cutting AI Push Collides With a $190 Billion Bet
Satya Nadella has sent an unusual message to Microsoft’s workforce: stop burning expensive frontier models on mundane tasks. The directive,...
Infineon’s €108 Target: Analyst Confidence Grows as AI Data Center Demand Fuels a 106% Rally
Infineon rarely gets mentioned in the same breath as Nvidia when investors talk about artificial intelligence. That perception is shifting...
From Groundbreaking to Sky-High Targets: Micron’s New York Megafab Marks a Pivotal Moment for AI Memory
The most ambitious private investment in New York’s history is moving from blueprint to bulldozer. Micron Technology has selected Bechtel...
Renk’s Long-Term Defence Pivot Clashes With a 45% Stock Wipeout
The Renk Group AG is doing a bold triple pivot: into unmanned ground vehicles, wheeled armour and independent US operations....
Popular
Net Worth
Diginex’s $1.5 Billion Goliath Gamble: A Penny Stock’s Fight for Survival and Nasdaq Listing
The clock is ticking for Diginex. With the deadline for a transformative $1.5 billion acquisition expiring on...
Palantir’s Revenue Jumps 85% to $1.63B, but CEO Karp Warns AI Industry Is Headed for Nationalization
Alex Karp is not one to mince words, and this week he took direct aim at the...
Heidelberg Druck’s Radical Overhaul: Production Moves East, Defense Venture Takes Shape Amid Cash Flow Strain
The market is taking notice of Heidelberger Druckmaschinen’s gamble. The SDax-listed printing press manufacturer saw its shares...
Ocugen’s Mutation-Agnostic Gene Therapy Edges Toward FDA Filing as $130M Financing Secures Runway to 2028
Ocugen is betting that a single therapeutic can rewrite the rules for treating inherited retinal diseases. Its...